FDA Clearance Tracker · P030019-S009
ORTHOVISC SODIUM HYALURONATE
Last checked: Nov 20, 2026Latest source record: Oct 26, 2007 (this decision)Source: openFDAMethods & limitations
Decided
Oct 26, 2007
Approved
Time to decision
546 days
Received Apr 28, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P030019-S009
- Device name
- ORTHOVISC SODIUM HYALURONATE
- Applicant
- Anika Therapeutics, Inc.
- Applicant location
- Beford, MA
- Received
- Apr 28, 2006
- Decided
- Oct 26, 2007
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P030019
Device type
- Device type
- Acid, hyaluronic, intraarticular (MOZ)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MODIFYING THE MANUFACTURING PROCESS FOR ORTHOVISC TO ONE THAT PRODUCES SODIUM HYALURONATE FROM BACTERIAL FERMENTATION. THE DEVICE IS INDICATED FOR THE TREATMENT OF PAIN IN OSTEOARTHRITIS (OA) OF THE KNEE IN PATIENTS WHO HAVE FAILED TO RESPOND ADEQUATELY TO CONSERVATIVE NON-PHARMACOLOGIC THERAPY AND TO SIMPLE ANALGESICS (E.G., ACETAMINOPHEN).
Source documents
Other decisions for Anika Therapeutics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261869 · Decided Sep 17, 2026 · 105 days after receipt
Device type: Fastener, Fixation, Nondegradable, Soft Tissue (MBI) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.